Sterile Filters Guard Drugs From Contamination

Pharmaceutical manufacturers around the world produce trillions of medication doses annually, and they sterilize each one using microscopic filters to remove dangerous contaminants. These filters, typically between 105 and 170 micrometers thick, operate on size exclusion, allowing small drug molecules to pass while blocking larger particles.

While effective, this process faces increasing challenges with complex new therapies like mRNA technology and nanotechnology, which can clog filters and lead to batch failures costing millions of dollars. Researchers are now investigating ways to improve filtration strategies, including using dual-layer membranes with varying pore sizes and carefully selecting prefilters based on chemical properties.

Recent studies show dual-layer membranes can increase filter capacity by over 50% and yield to over 94%. The sterile filtration market is projected to reach nearly $13 billion by 2035 as the industry develops more complex drugs, emphasizing the need for innovative sterilization methods to ensure both safety and affordability.